Alpha-1 Antitrypsin Deficiency Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Alvelestat (MPH996) for the Treatment of ALpha-1 ANTitrypsin Deficiency
Conditions: Alpha-1 Antitrypsin Deficiency (AATD); Pi*ZZ, Pi*SZ, or Pi*Null Phenotype; Emphysema or COPD Interventions: Drug: Alvelestat (MPH996); Other: Placebo Sponsors: University of Alabama at Birmingham; National Institutes of Health (NIH); Mereo BioPharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 20, 2018 Category: Research Source Type: clinical trials
AKI Cardiosurgery Diagnostic Study (AKI-CDS)
Conditions: Acute Kidney Injury; Renal Replacement Therapy Intervention: Diagnostic Test: Biomarker ( " penKid " , adrenomedulin, C-terminal alpha-1 antitrypsin peptide) Sponsor: University of Rostock Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2018 Category: Research Source Type: clinical trials
